Figure 7.

The results of Stage II CHNRI process – an expert opinion exercise assessing the potential usefulness of investment in monoclonal antibodies for passive immunization of infants against RSV. CHNRI- Child Health and Nutrition Research Initiative

Nair et al. BMC Public Health 2011 11(Suppl 3):S30   doi:10.1186/1471-2458-11-S3-S30